ECHA No dermal adverse efects Paraffinum liquidum Registration Dossier

1/25/2019
White mineral oil (petroleum) - Registration Dossier - ECHA
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
REACH
White mineral oil (petroleum)
EC number: 232-455-8 | CAS number: 8042-47-5
A highly refined petroleum mineral oil consisting of a complex combination of hydrocarbons obtained from the intensive treatment of a petroleum fraction
with sulfuric acid and oleum, or by hydrogenation, or by a combination of hydrogenation and acid treatment. Additional washing and treating steps may be
included in the processing operation. It consists of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C50.
Toxicological information
Repeated dose toxicity: dermal
001 Key | Read-across (Category)
Administrative data
Endpoint:
sub-chronic toxicity: dermal
Type of information:
migrated information: read-across based on grouping of substances (category approach)
Adequacy of study:
key study
Study period:
Not reported
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: This study is classified as reliable without restrictions because it was carried out according
to OECD test guideline 411 and GLP.
Justification for type of information:
https://echa.europa.eu/es/registration-dossier/-/registered-dossier/15514/7/6/4
1/11
1/25/2019
White mineral oil (petroleum) - Registration Dossier - ECHA
Concawe believes that dermal is the most relevant exposure route, and is sufficiently robust, to
identify any potential hazards from repeated exposures to petroleum products to be able to
adequately manage the potentially associated risks. However, the primary objective of the testing
required for REACH is the identification of hazard, for which the default exposure route under the
regulation is oral as this is considered to maximise systemic exposure. To address the regulatory
exposure route issue, Concawe will review the current data base for evidence of systemic toxicity
after dermal exposure and will also conduct a number of oral OECD 422 studies on prioritized
substances in each relevant petroleum category. The document attached provides a concise
overview of the information to further support the dermal route of exposure and proposed
additional work, as part of a larger testing strategy (the strategy document can be found in Annex
13).
Data source
Reference
Reference Type:
study report
Title:
Unnamed
Year:
1988
Report Date:
1988
Materials and methods
https://echa.europa.eu/es/registration-dossier/-/registered-dossier/15514/7/6/4
2/11
1/25/2019
White mineral oil (petroleum) - Registration Dossier - ECHA
Test guideline
Qualifier:
according to
Guideline:
OECD Guideline 411 (Subchronic Dermal Toxicity: 90-Day Study)
GLP compliance:
yes
Limit test:
no
Test material
Reference
Name:
Unnamed
Type:
Constituent
Type:
Constituent
Test material form:
other: Oily liquid
Details on test material:
Test material name: Stock 461 (80" white oil)
Lot No.: CRU #85018
Manufacturer: Witco Chemical Company
Density: 0.88 g/mL
-Substance Type: Highly Refined Base Oil
- Stability under test conditions: Stable for a minimum of 2 years
- Storage condition of test material: Room temperature under ventilated hood
Test animals
https://echa.europa.eu/es/registration-dossier/-/registered-dossier/15514/7/6/4
3/11
1/25/2019
White mineral oil (petroleum) - Registration Dossier - ECHA
Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals and environmental
conditions:
No data reported.
TEST ANIMALS
- Source: Charles River Breeding Laboratories, Inc., Lakeview, New Jersey
- Age at study initiation: 6 to 8 weeks
- Weight at study initiation: 244 to 253 g (males), 167 to 176 g (females)
- Housing: Individual
- Diet (e.g. ad libitum): Ad libitum
- Water (e.g. ad libitum): Ad libitum
- Acclimation period: 3 weeks
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 to 22°C
- Humidity (%): 40 to 60%
- Photoperiod (hrs dark / hrs light): 12 hrs dark / 12 hrs light
IN-LIFE DATES: From: June 18, 1985 To: October 5, 1985
Administration / exposure
Type of coverage:
open
Vehicle:
unchanged (no vehicle)
Details on exposure:
TEST SITE
- Area of exposure: clipped dorsal skin
- % coverage: not reported
- Time intervals for shavings or clippings: weekly
https://echa.europa.eu/es/registration-dossier/-/registered-dossier/15514/7/6/4
4/11
1/25/2019
mineral SUBSTANCE
oil (petroleum) - Registration Dossier - ECHA
REMOVALWhite
OF TEST
Test substance not removed
TEST MATERIAL
- Constant volume or concentration used: yes
USE OF RESTRAINERS FOR PREVENTING INGESTION: yes
Analytical verification of doses or
concentrations:
not specified
Details on analytical verification of doses or
concentrations:
No data reported.
Duration of treatment / exposure:
13 weeks of exposure
Frequency of treatment:
daily
Doses / concentrations
Remarks:
Doses / Concentrations:
0, 125, 500, or 2000 mg/kg/day
Basis:
nominal per unit body weight
No. of animals per sex per dose:
10 per sex per dose
Control animals:
other: yes, sham-exposed and no treatment control groups
Details on study design:
- Dose selection rationale: At 2000 mg/kg, test material was a dermal irritant and produced slight
maternal toxicity during gestation; 2000 mg/kg is the maximum practical dose that can be applied
dermally; the selection of the low and mid-dose levels was based on results obtained from a
methods development project
Positive control:
None
https://echa.europa.eu/es/registration-dossier/-/registered-dossier/15514/7/6/4
5/11
Examinations
1/25/2019
White mineral oil (petroleum) - Registration Dossier - ECHA
Observations and examinations performed and CAGE SIDE OBSERVATIONS: Yes
frequency:
- Time schedule: daily
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: daily
DERMAL IRRITATION (if dermal study): Yes
- Time schedule for examinations: daily
BODY WEIGHT: Yes
- Time schedule for examinations: weekly
FOOD CONSUMPTION:
- Food consumption for each animal determined and mean daily diet consumption calculated as g
food/kg body weight/day: Yes
HAEMATOLOGY: Yes
- Time schedule for collection of blood: during the week prior to scheduled termination
- Parameters checked in table 1 were examined.
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: during the week prior to scheduled termination
- Animals fasted: No data
- Parameters checked in table 2 were examined.
URINALYSIS: Yes
- Time schedule for collection of urine: during the week prior to scheduled termination
- Metabolism cages used for collection of urine: No
- Animals fasted: No data
- Parameters checked in table 3 were examined.
NEUROBEHAVIOURAL EXAMINATION: No
https://echa.europa.eu/es/registration-dossier/-/registered-dossier/15514/7/6/4
6/11
1/25/2019
White mineral oil (petroleum) - Registration Dossier - ECHA
Sacrifice and pathology:
GROSS PATHOLOGY: Yes
HISTOPATHOLOGY: Yes
Other examinations:
No data reported.
Statistics:
No data reported.
Results and discussion
Results of examinations
Clinical signs:
no effects observed
Dermal irritation:
effects observed, treatment-related
Mortality:
no mortality observed
Body weight and weight changes:
effects observed, treatment-related
Food consumption and compound intake (if
feeding study):
no effects observed
Food efficiency:
not examined
Water consumption and compound intake (if
drinking water study):
not examined
Ophthalmological findings:
not examined
Haematological findings:
no effects observed
Clinical biochemistry findings:
no effects observed
Urinalysis findings:
no effects observed
Behaviour (functional findings):
not examined
https://echa.europa.eu/es/registration-dossier/-/registered-dossier/15514/7/6/4
7/11
1/25/2019
White mineral oil (petroleum) - Registration Dossier - ECHA
Organ weight findings including organ / body
weight ratios:
no effects observed
Gross pathological findings:
no effects observed
Histopathological findings: non-neoplastic:
no effects observed
Histopathological findings: neoplastic:
not examined
Details on results:
Administration of the test material to the skin produced skin irritation at all dose levels, which
included erythema, flaking of the skin, and scabs at the site of test material application.
Male and female rats dosed at 500 and 2000 mg/kg bw/day showed a decrease in body weight
when compared to the controls, and was a statistically significant decrease for males exposed to
500 and 2000 mg/kg bw/day and females exposed to 2000 mg/kg bw/day.
Urinalysis results showed an increase in ketone levels for males in the sham control group and
exposed to the test material, when compared to the untreated control group.
Male serum albumin and albumin/globulin ratio for the 2000 mg/kg bw/day group were
significantly different from that of the control group.
Urinalysis and haematological effects were of doubtful toxicological significance.
There were no other compound-related effects on mortality, clinical signs, food consumption, organ
weights, clinical chemistry.
Effect levels
1
Dose descriptor:
NOAEL
Remarks:
systemic effects
https://echa.europa.eu/es/registration-dossier/-/registered-dossier/15514/7/6/4
8/11
1/25/2019
White mineral oil (petroleum) - Registration Dossier - ECHA
Effect level:
>= 2 000 mg/kg bw/day (nominal)
Sex:
male/female
Basis for effect level:
other: no systemic effects were considered to be significant
2
Dose descriptor:
NOAEL
Remarks:
local effects
Effect level:
< 125 mg/kg bw/day (nominal)
Sex:
male/female
Basis for effect level:
other: based on skin irritation
Target system / organ toxicity
Critical effects observed:
not specified
Applicant's summary and conclusion
Conclusions:
The NOAEL for local effects is < 125 mg/kg based on skin irritation, while the NOAEL for systemic
effects is greater than or equal to 2000 mg/kg, in the absence of significant toxicological findings
of concern.
Executive summary:
https://echa.europa.eu/es/registration-dossier/-/registered-dossier/15514/7/6/4
9/11
1/25/2019
White mineral oil (petroleum) - Registration Dossier - ECHA
In a 90-day dermal toxicity study,80SUS white mineral oil was applied to the
clipped skin of 10 Sprague-Dawley rats/sex/dose at dose levels of 0, 125, 500, or
2000 mg/kg bw/day during a 90-day period.
Administration of the test material to the skin produced skin irritation at all dose
levels, which included erythema, flaking of the skin, and scabs at the site of test
material application. Male and female rats dosed at 500 and 2000 mg/kg bw/day
showed a decrease in body weight when compared to the controls, and was a
statistically significant decrease for males exposed to 500 and 2000 mg/kg
bw/day and females exposed to 2000 mg/kg bw/day. Urinalysis and
haematological effects were of doubtful toxicological significance. There were no
other compound-related effects on mortality, clinical signs, food consumption,
organ weights, clinical chemistry. The NOAEL for local effects is < 125 mg/kg
based on skin irritation, while the NOAEL for systemic effects is greater than or
equal to 2000 mg/kg, in the absence of significant toxicological findings of
concern.
This study received a Klimisch score of 1 and is classified as reliable without
restrictions because it was carried out according to OECD test guideline 411 and
GLP.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number.
The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the
dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or
verified by the Agency or any other authority. The content is subject to change without prior notice.
https://echa.europa.eu/es/registration-dossier/-/registered-dossier/15514/7/6/4
10/11
1/25/2019
Reproduction
White
mineral to
oil (petroleum)
Registration Dossier
- ECHA
or further distribution of this information may be
subject
copyright- protection.
Use of
the information without
obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
https://echa.europa.eu/es/registration-dossier/-/registered-dossier/15514/7/6/4
11/11